Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 26.76x is 190% above its 5-year average of -29.66x, near the high end of its 5-year range (-86.57x–26.76x).
198.71% above its 12-month average of -27.11x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): -23.60x.
INTEREST COVERAGE RATIO
26.76x
INTEREST COVERAGE RATIO AVG TTM
-27.11x
INTEREST COVERAGE RATIO AVG 3Y
-26.20x
INTEREST COVERAGE RATIO AVG 5Y
-29.66x
INTEREST COVERAGE RATIO AVG 10Y
-27.25x
INTEREST COVERAGE RATIO AVG 15Y
-26.17x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+198.71%
CURRENT VS 3Y AVG
+202.16%
CURRENT VS 5Y AVG
+190.24%
CURRENT VS 10Y AVG
+198.20%
CURRENT VS 15Y AVG
+202.24%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 476 covered companies
CURRENT VS SECTOR MEDIAN
+562.18%
vs the sector median at left
Pluri Inc.
Market Cap
$11.54M
Interest Coverage Ratio
26.76x
TTM Avg
-27.11x
3Y Avg
-26.20x
5Y Avg
-29.66x
Market Cap
$11.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.44M
Interest Coverage Ratio
-20.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.19M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.17M
Interest Coverage Ratio
-473.91x
TTM Avg
210.31x
3Y Avg
210.31x
5Y Avg
210.31x
Market Cap
$12.28M
Interest Coverage Ratio
N/A
TTM Avg
4.58x
3Y Avg
5.23x
5Y Avg
12.43x
Market Cap
$10.73M
Interest Coverage Ratio
-309.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pluri Inc. (PLUR) | $11.54M | 26.76x | -27.11x | -26.20x | -29.66x |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.61M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.44M | -20.24x | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.19M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | -473.91x | 210.31x | 210.31x | 210.31x |
| BioVie Inc. (BIVI)vs › | $11.12M | -1265.39x | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.08M | -4.24x | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.28M | N/A | 4.58x | 5.23x | 12.43x |
| Caring Brands, Inc. (CABR)vs › | $10.73M | -309.66x | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.68M | -1.99x | N/A | N/A | N/A |
Interest Coverage
26.8x
Debt/Equity
N/A
Current Ratio
0.27
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -23.60x |
| 2026-03-31 | -27.64x |
| 2025-12-31 | -28.16x |
| 2025-09-30 | -27.73x |
| 2025-06-30 | -28.42x |
| 2025-03-31 | -25.47x |
| 2024-12-31 | -23.49x |
| 2024-09-30 | -23.95x |
| 2024-06-30 | -27.68x |
| 2024-03-31 | -25.39x |
| 2023-12-31 | -24.13x |
| 2023-09-30 | -25.13x |
| 2023-06-30 | -29.75x |
| 2023-03-31 | -32.72x |
| 2022-12-31 | -31.50x |
| 2022-09-30 | -35.69x |
| 2022-06-30 | -42.09x |
| 2022-03-31 | -86.57x |
| 2021-12-31 | -35.86x |
| 2021-09-30 | -45.04x |
| 2021-03-31 | -92.37x |
| 2020-12-31 | -103.76x |
| 2020-09-30 | -164.85x |
| 2019-12-31 | -3184.00x |
| 2019-06-30 | -273.48x |
| 2018-12-31 | -23.67x |
| 2018-06-30 | -1.04x |
| 2017-06-30 | -11.36x |
| 2016-06-30 | -99.56x |
| 2015-09-30 | -15.65x |
| 2015-06-30 | -157.14x |
| 2014-09-30 | -19.52x |
| 2014-06-30 | -35.15x |
| 2013-06-30 | -11.93x |
| 2012-06-30 | -24.21x |
| 2011-09-30 | -26.91x |
| 2010-06-30 | -49.20x |
| 2010-03-31 | -451.60x |
| 2009-12-31 | -202.44x |
| 2009-06-30 | -11.38x |
| 2009-03-31 | -22.74x |
| 2008-12-31 | -40.65x |
